Canada Pharmaceuticals and Healthcare Report Q1 2015

Business Monitor International
December 10, 2014
112 Pages - SKU: BMI5405739
Countries covered: Canada

Canada Pharmaceuticals and Healthcare Report Q1 2015

BMI View: Canada's epidemiological profile will continue to be attractive to manufacturers of medicinesfor non-communicable diseases. Despite the relatively rapid uptake of innovative pharmaceuticals, theburden of chronic conditions will increase over the next 15 years. Like many other developed states,Canada is introducing cost-containment measures to restrict the commercial opportunities presented todrugmakers.

Headline Expenditure Projections

Pharmaceuticals: CAD25.6bn (USD24.9bn) in 2013 to CAD25.8bn (USD23.3bn) in 2014; +0.8% inlocal currency terms and -6.5% in US dollar terms. Forecast unchanged from Q414.

Healthcare: CAD204.3bn (USD198.4bn) in 2013 to CAD211.9bn (USD190.9bn) in 2014; +3.7% inlocal currency terms and -3.8% in US dollar terms. Forecast unchanged from Q414.



More Prescription Drugs reports by Business Monitor International

Taiwan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Taiwan Pharmaceuticals and Healthcare Report Q1 2015BMI View: Taiwan is one of the most attractive and stable prospects in the region for pharmaceutical andhealthcare investment, ...
Switzerland Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Switzerland Pharmaceuticals and Healthcare Report Q1 2015BMI View: The Swiss government will need to develop policies to maintain the country's long-termattractiveness as a site for ...
Sudan Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Sudan Pharmaceuticals and Healthcare Report Q1 2015BMI View: The already depreciating Sudanese pound will come under further strain should oil pricescontinue their decline as oil ...
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015 by Business Monitor International
Saudi Arabia Pharmaceuticals and Healthcare Report Q1 2015BMI View: We expect heavy investment into Saudi Arabia's healthcare sector to continue, particularly asthe government sees the ...
See all reports like this >>

More Canada Prescription Drugs reports

Pharmaceuticals in Canada by MarketLine
Pharmaceuticals in CanadaIntroductionPharmaceuticals in Canada industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2009-13, and forecast to 2018). ...
Canada Pharmaceutical Industry by Aruvian's R'search
Canada Pharmaceutical IndustryThe Canadian pharmaceutical market is the eighth largest in the world, accounting for about two percent of the world market by sales. Canada ...
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022 by GlobalData
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022SummaryDuring the forecast period from 2012-2022, the growth of the UC market will be ...
Pharmaceuticals in Canada: ISIC 2423 by Euromonitor International
Pharmaceuticals in Canada: ISIC 2423Euromonitor International's Industrial reports provide a 360 degree view of an industry. The Industrial market report offers a comprehensive guide to ...
See all reports like this >>

 

SELECT A LICENSE

    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!